APA (7th ed.) Citation

S, P., RJ, S., I, D. P., T, S., A, W., L, C., . . . SV, L. (2026). Real-world outcomes versus clinical trial results of first-line immunotherapy with or without chemotherapy in patients with metastatic non-small-cell lung cancer: The CORRELATE study. ESMO open, 11(1), 106031. https://doi.org/10.1016/j.esmoop.2025.106031

Chicago Style (17th ed.) Citation

S, Peters, Salomonsen RJ, Diaz Perez I, Shcherbakova T, Wang A, Cai L, Sadow S, and Liu SV. "Real-world Outcomes Versus Clinical Trial Results of First-line Immunotherapy with or Without Chemotherapy in Patients with Metastatic Non-small-cell Lung Cancer: The CORRELATE Study." ESMO Open 11, no. 1 (2026): 106031. https://doi.org/10.1016/j.esmoop.2025.106031.

MLA (9th ed.) Citation

S, Peters, et al. "Real-world Outcomes Versus Clinical Trial Results of First-line Immunotherapy with or Without Chemotherapy in Patients with Metastatic Non-small-cell Lung Cancer: The CORRELATE Study." ESMO Open, vol. 11, no. 1, 2026, p. 106031, https://doi.org/10.1016/j.esmoop.2025.106031.